Treatment of major depression in adolescents: Weighing the evidence of risk and benefit in light of black box warnings

Journal of Child and Adolescent Psychiatric Nursing

Volumn 22, Issue 2, 2009, Pages 63-68

  Lovrin, Mellen ^a,b  

^a St Francis Hospital   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Adolescents; Depression; SSRIs; Suicidality

Indexed keywords

ANTIDEPRESSANT AGENT; SEROTONIN UPTAKE INHIBITOR;

ADOLESCENT; CASE REPORT; COOPERATION; DRUG LABELING; EVIDENCE BASED MEDICINE; FEMALE; HUMAN; INTERDISCIPLINARY COMMUNICATION; MAJOR DEPRESSION; MULTIMODALITY CANCER THERAPY; NURSING; PATIENT EDUCATION; PRACTICE GUIDELINE; PSYCHOANALYSIS; PSYCHOLOGICAL ASPECT; REVIEW; RISK ASSESSMENT; SUICIDE;

ADOLESCENT; ANTIDEPRESSIVE AGENTS; COMBINED MODALITY THERAPY; COOPERATIVE BEHAVIOR; DEPRESSIVE DISORDER, MAJOR; DRUG LABELING; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; INTERDISCIPLINARY COMMUNICATION; PATIENT EDUCATION AS TOPIC; PRACTICE GUIDELINES AS TOPIC; PSYCHOANALYTIC THERAPY; RISK ASSESSMENT; SEROTONIN UPTAKE INHIBITORS; SUICIDE;

EID: 70349771529     PISSN: 10736077     EISSN: 17446171     Source Type: Journal    
DOI: 10.1111/j.1744-6171.2009.00174.x     Document Type: Article

References (26)

1. Alex, K. D., Yavanian, G. J., McFarlane, H. G., Pluto, C. P., & Pehek, E. A. (2005). Modulation of dopamine release by striatal 5-HT2C receptors. Synapse , 15 ; 55 (4), 242-251.
2. American Academy of Child and Adolescent Psychiatry. (1998). Practice parameters for the assessment and treatment of children and adolescents with depressive disorders. Journal of the American Academy of Child and Adolescent Psychiatry , 37 (10 Suppl.), 63S- 83S.
3. American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed., Text Rev.). Washington, DC: Author.
4. Anderson A. N. & Smith, B. L. (2003). Deaths: leading causes. National Vital Statistics Report , 52 (9), 1-85.
5. Diamond, G. M., Liddle, H. A., Hogue, A., & Dakof, G. A. (1999). Alliance-building interventions with adolescents in family therapy: A process study. Psychotherapy: Theory, Research, Practice, Training , 36 (4), 355-368
6. Emslie, G., Kratochvil, C., Vitiello, B., Silva, S., Mayes, T., McNulty, S., et al. (2006). Treatment for Adolescents With Depression Study (TADS): safety results. Journal of the American Academy of Child and Adolescent Psychiatry , 45 , 1440-1455.
7. Food and Drug Administration. (2004a). Antidepressant use in children, adolescents, and adults . Retrieved January 28, 2007, http://www. fda.gov/cder/drug/antidepressants/
8. Food and Drug Administration. (2004b). Labeling change request letter for antidepressant medications . Retrieved January 28, 2007, http:// www.fda.gov.cder/drug/antidepressants/SSRIPHA200410.htm
9. Hassad, T. A., Laughren, T., & Racoosin, J. (2006). Suicidality in pediatric patient treated with antidepressant drugs. Archives of General Psychiatry , 63 , 332-339.
10. Jensen, P. S. (2006). After TADS, can we measure up, catch up, and ante up? Journal of the American Academy of Child and Adolescent Psychiatry , 45 (12), 1456-1460.
11. Leon, A. C., Marzuk, P. M. Tardiff, K., Bucciarelli, A., Piper, T. M., & Galea, S. (2006). Antidepressants and youth suicide in New York City, 1999-2002. American Journal of Child and Adolescent Psychiatry , 45 (9), 1054-1057.
12. Liddle, H. A., & Schwartz, S. J. (2002). Attachment and family therapy: Clinical utility of adolescent-family attachment research. Family Process , 41 , 455-476.
13. March, J., Silva, S., Vitiello, B., and the TADS Team. (2006). The treatment for adolescents with depression study (TADS): methods and message at 12 weeks. Journal of the American Academy of Child and Adolescent Psychiatry , 45 (12), 1393-1403.
14. Martin, J., Romas, R., Medford, M., Leffert, N., & Hatcher, S. L. (2006). Adult helping qualities preferred by adolescents. Adolescence , 41 (161), 127-139.
15. Masand, P. S. (2003). Tolerability and adherence issues in antidepressant therapy. Clinical Therapeutics , 25 (8), 2289-2303.
16. Medicines and Healthcare products Regulatory Agency. (2004). Experts complete review on safety of antidepressants . Retrieved May 20, 2007, from http://www.mhra.gov.uk/home
17. Moreno, C., Roche, A. M., & Greenhill, L. L. (2006). Pharmacotherapy of child and adolescent depression. Child and Adolescent Psychiatric Clinics of North America , 15 , 977-998.
18. National Institute for Health and Clinical Excellence. (2004). Depression in children and young people . London: Author.
19. Persons, J., & Silberschatz, G. (1998). Are results of randomized controlled trials useful to psychotherapists? Journal of Consulting and Clinical Psychology , 66 , 126-135.
20. Ruland, C. M. (1999). Decision support for patient preference-based care planning. Effects on nursing care and patient outcomes. Journal of the American Medical Informatics Association , 6 , 304-312.
21. Schatzberg, A. F., & Nemeroff, C. B. (2004). Textbook of psychopharmacology , 3rd ed. Washington, DC: American Psychiatric Publishing.
22. Schatzberg, A. F., Cole, J. O., & DeBattista, C. (2005). Manual of clinical psychopharmacology , 5th ed. Washington, DC: American Psychiatric Publishing.
23. Simon, G. E. (2007). The antidepressant quandary-considering suicide risk when treating adolescent depression. New England Journal of Medicine , 355 (26), 2722-2723.
24. Spratto, G. R., & Woods, A. L. (2006). PDR nurse's drug handbook, 2006 edition . Clifton Park, NY: Thomson Delmar Learning.
25. Vedantam, S. (2004, September 13). FDA confirms antidepressants raise children's suicide risk. Washington Post . Retrieved January 28, 2007, from www.washingtonpost.com/wp-dyn/articles/ A1879102004Sept13.html
26. Whittington, C. J., Kendall, T., Fonagy, P., Cottrell, D., Cotgrove, A., & Boddington, E. (2004). Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data. Lancet , 363 (9418), 1341-1345.